The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
Also known as: Triiodothyronine
Also known as: Free T3, FT3, T3 Free
Also known as: T4 Thyroxine Total
Also known as: Free T4, FT4, T4 Free
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
The Thyroid, T4, FT4, T3 Up, TSH, FT3, T3 Total, T3R panel contains 7 tests with 9 biomarkers.
Brief Description: The Thyroid, T4, FT4, T3 Up, TSH, FT3, T3 Total, T3R Panel is a detailed assessment of thyroid function, providing a comprehensive overview of the thyroid hormone production, metabolism, and regulatory mechanisms. This panel includes measurements of both bound and unbound forms of thyroxine (T4) and triiodothyronine (T3), the thyroid-stimulating hormone (TSH), and the reverse T3 (T3R), offering insights into various aspects of thyroid health. This in-depth analysis is crucial for diagnosing thyroid disorders, guiding treatment decisions, and monitoring the effectiveness of interventions.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Specifc to TSH: Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks.
According to the assay manufacturer Siemens: "Samples containing fluorescein can produce falsely depressed values when tested with the Advia Centaur TSH3 Ultra assay."
This panel is typically ordered for individuals presenting symptoms suggestive of thyroid dysfunction, such as unexpected weight changes, mood fluctuations, changes in energy levels, or irregularities in heart rate. It's also crucial for monitoring patients with known thyroid disorders, assessing the efficacy of ongoing treatment, and adjusting therapeutic approaches based on comprehensive hormonal feedback.
Measures the level of reverse T3, an inactive form of T3 that can increase in conditions of thyroid dysfunction and in non-thyroidal illness.
Assesses the total amount of triiodothyronine, including both the free and bound forms, providing a general overview of T3 availability.
Evaluates the binding capacity of proteins that carry thyroid hormones in the blood, offering indirect information about thyroid function and hormone availability.
Measures the unbound, active form of T3, giving insight into the metabolic activity driven by thyroid hormones.
Determines the total concentration of thyroxine, including both bound and free forms, to assess overall thyroid hormone production.
Measures the unbound, active form of T4, which is a precursor for T3 and crucial for understanding thyroid health.
Evaluates the level of thyroid-stimulating hormone, which is produced by the pituitary gland and regulates thyroid hormone production.
Hypothyroidism
Characterized by reduced thyroid hormone production, leading to a slowdown in metabolic processes. High TSH and low FT4/FT3 levels typically indicate this condition.
Hyperthyroidism
Marked by excessive thyroid hormone production, accelerating metabolism. Low TSH and high FT4/FT3 levels usually suggest hyperthyroidism.
Thyroiditis
Refers to inflammation of the thyroid, which can cause transient hyperthyroidism followed by hypothyroidism. The panel tracks the progression of thyroid hormone levels through these phases.
Non-thyroidal Illness Syndrome
Characterized by abnormal findings on thyroid function tests due to a non-thyroidal illness, with elevated T3R as a key marker.
Hypothyroidism
Treatment typically involves thyroid hormone replacement therapy. Regular monitoring of TSH and FT4 levels helps adjust medication dosage to ensure optimal thyroid function.
Hyperthyroidism
Treatment options include antithyroid medications, radioactive iodine, or surgery. Monitoring TSH, FT4, and FT3 levels guides the treatment's effectiveness and dosage adjustments.
Thyroiditis
Management may vary depending on the condition's phase. The comprehensive nature of the panel allows for close monitoring of thyroid function changes, guiding treatment accordingly.
Non-thyroidal Illness Syndrome
Treatment focuses on the underlying illness. T3R levels, along with other markers, help distinguish this condition from primary thyroid disorders, guiding appropriate management strategies.
The Thyroid, T4, FT4, T3 Up, TSH, FT3, T3 Total, T3R Panel provides an essential tool for diagnosing and managing thyroid disorders, offering a detailed picture of thyroid hormone production, regulation, and action. By evaluating the intricate balance of thyroid hormones and their regulators, healthcare professionals can develop targeted treatment strategies, monitor disease progression, and adjust therapies as needed to manage conditions effectively and improve patient outcomes.